CN110339069A - A kind of firm medicament - Google Patents
A kind of firm medicament Download PDFInfo
- Publication number
- CN110339069A CN110339069A CN201910754472.9A CN201910754472A CN110339069A CN 110339069 A CN110339069 A CN 110339069A CN 201910754472 A CN201910754472 A CN 201910754472A CN 110339069 A CN110339069 A CN 110339069A
- Authority
- CN
- China
- Prior art keywords
- parts
- firm
- medicament according
- superfines
- methyl ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 229920001577 copolymer Polymers 0.000 claims abstract description 24
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 20
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 19
- HHEHWCIYDICHCG-ODZAUARKSA-N (z)-but-2-enedioic acid;methoxyethene Chemical compound COC=C.OC(=O)\C=C/C(O)=O HHEHWCIYDICHCG-ODZAUARKSA-N 0.000 claims abstract description 16
- 239000004200 microcrystalline wax Substances 0.000 claims abstract description 14
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 14
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 14
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 11
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 11
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 11
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 239000000022 bacteriostatic agent Substances 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 12
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims description 10
- -1 alkyl formate Chemical compound 0.000 claims description 10
- 230000000845 anti-microbial effect Effects 0.000 claims description 8
- 239000003086 colorant Substances 0.000 claims description 8
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 8
- 239000004014 plasticizer Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 229940057995 liquid paraffin Drugs 0.000 claims description 7
- 108010014251 Muramidase Proteins 0.000 claims description 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 6
- 235000010335 lysozyme Nutrition 0.000 claims description 6
- 239000004325 lysozyme Substances 0.000 claims description 6
- 229960000274 lysozyme Drugs 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- 239000003549 soybean oil Substances 0.000 claims description 6
- 235000012424 soybean oil Nutrition 0.000 claims description 6
- 229940099259 vaseline Drugs 0.000 claims description 6
- 241000241413 Propolis Species 0.000 claims description 5
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims description 5
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims description 5
- 229940069949 propolis Drugs 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229940105902 mint extract Drugs 0.000 claims description 4
- 239000002781 deodorant agent Substances 0.000 claims description 3
- 102000016943 Muramidase Human genes 0.000 claims 2
- 244000269722 Thea sinensis Species 0.000 claims 2
- 150000005204 hydroxybenzenes Chemical class 0.000 claims 1
- 241001122767 Theaceae Species 0.000 abstract description 13
- 230000003115 biocidal effect Effects 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract description 3
- 235000015110 jellies Nutrition 0.000 abstract description 3
- 239000008274 jelly Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000002861 polymer material Substances 0.000 abstract description 3
- 210000003296 saliva Anatomy 0.000 abstract description 3
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 102100033468 Lysozyme C Human genes 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 101710132699 Lysozyme 2 Proteins 0.000 description 1
- 102100026848 Lysozyme-like protein 2 Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
- A61K6/19—Self-expanding, e.g. for filling teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
- A61K6/35—Preparations for stabilising dentures in the mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/898—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a kind of firm medicaments, including according to raw material made of following number proportion: 25-45 parts of vinyl methyl ether maleic acid inorganic salt copolymer superfines, 10-15 parts of carboxymethyl cellulose, 3-5 parts of microwax, 5-8 parts of auxiliary agent, 3-5 parts of alkyl parabens, 1-4 parts of tea polyphenols and 15-20 parts of carrier.When agent for fixing component and saliva of the invention contacts, polymer material has water-swellable and forms the property of jelly, and fill the space between artificial tooth and gum, form buffer layer, and it improves bonding force lasting between artificial tooth and gums and can be improved the safety used, the entire product that addition microwax, alkyl parabens, tea polyphenols and carrier refer in inventive formulation simultaneously can remove original smell, keep certain faint scent, have the advantages that biocidal efficacies.
Description
Technical field
The present invention relates to a kind of technical field of the study of denture adhesive, especially a kind of firm medicament.
Background technique
The study of denture adhesive is a kind of paste-type adhesive for assisting artificial tooth to wear, it acts on basal seat area tissue surface, is absorbed
Expansion makes artificial tooth and mucous membrane of mouth close adhesion after saliva, achievees the purpose that raising denture retention and stable, to improve artificial tooth
The comfort of wearing, the degree of awareness are gradually increasing.Simple general introduction the study of denture adhesive effect is as follows: 1, reduces artificial tooth pair
The stimulation of gum, to effectively keep oral health；2, the study of denture adhesive are effectively hindered by artificial tooth and the more firm fitting of gum
Only swill enters；3, improve the adhesiveness of artificial tooth and oral cavity, enhancing bite force etc..It is suitable for full mouth and local movements
Artificial tooth.
But existing the study of denture adhesive is overweight with respect to taste, and contains zinc in main component, and zinc overdose influences peace
Full property and health.
Summary of the invention
It is steady that a kind of one kind for improving safety is provided the purpose of the present invention is to solve above-mentioned the deficiencies in the prior art
Gu medicament.
To achieve the goals above, a kind of firm medicament designed by the present invention, including matched according to following number
Raw material: 25-45 parts of vinyl methyl ether maleic acid inorganic salt copolymer superfines, 10-15 parts of carboxymethyl cellulose, microwax
3-5 parts, 5-8 parts of auxiliary agent, 3-5 parts of alkyl parabens, 1-4 parts of tea polyphenols and 15-20 parts of carrier.
Preferably, the auxiliary agent includes plasticizer, colorant, preservative, aromatic, antimicrobial, bacteriostatic agent, removes
One of smelly dose or a variety of.
Preferably, the bacteriostatic agent includes Honegsukle flower P.E, propolis, Paeonol, salt.
Preferably, the aromatic is mint extract.
Preferably, including according to raw material made of following number proportion: the inorganic salt copolymer of vinyl methyl ether maleic acid
35 parts of superfines, 12 parts of carboxymethyl cellulose, 4 parts of microwax, 6 parts of auxiliary agent, 4 parts of alkyl parabens, 3 parts of tea polyphenols
And carrier 18.
Preferably, the powdered molecular amount 800000-of the inorganic salt copolymer superfines of vinyl methyl ether maleic acid
1500000。
Preferably, the inorganic salt copolymer superfines of vinyl methyl ether maleic acid impacts powder by high speed machine
Broken, air-flow crushing, high speed ball mill grinding obtain.
Preferably, the carrier is one of liquid paraffin, vaseline, olive oil, soybean oil or a variety of.
Preferably, further including 1-2 parts of lysozyme.
Preferably, 2 parts of the lysozyme.
When a kind of firm medicament that the present invention obtains, agent for fixing component of the invention and saliva contact, polymer material tool
There is water-swellable and form the property of jelly, and fill the space between artificial tooth and gum, forms buffer layer, and improve artificial tooth
Lasting bonding force and can be improved the safety used between gums, at the same added in inventive formulation microwax,
The entire product that alkyl parabens, tea polyphenols and carrier refer to can remove original smell, keep certain faint scent, tool
There is the advantages of biocidal efficacies.
Specific embodiment
Innovation and creation are described further below with reference to embodiment.
Embodiment 1:
A kind of firm medicament provided in this embodiment, including according to raw material made of following number proportion: vinyl methyl ether Malaysia
Inorganic 25-45 parts of the salt copolymer superfines of acid, 10-15 parts of carboxymethyl cellulose, 3-5 parts of microwax, 5-8 parts of auxiliary agent, hydroxyl
3-5 parts of benzoic acid alkyl base ester, 1-4 parts of tea polyphenols and 15-20 parts of carrier.
The firm medicament in the present embodiment, including according to raw material made of following number proportion: vinyl methyl ether
40 parts of the inorganic salt copolymer superfines of maleic acid, 12 parts of carboxymethyl cellulose, microwax 4,6 parts of auxiliary agent, hydroxybenzoic acid alkane
3.5 parts of base ester, 2 parts of tea polyphenols and carrier 18 part.
Preferably, the auxiliary agent includes plasticizer, colorant, preservative, aromatic, antimicrobial, bacteriostatic agent, removes
One of smelly dose or a variety of.The auxiliary agent includes plasticizer, colorant, preservative in the present embodiment.
Preferably, the powdered molecular amount 800000- of the inorganic salt copolymer superfines of vinyl methyl ether maleic acid
1500000.The powdered molecular amount of the inorganic salt copolymer superfines of the vinyl methyl ether maleic acid in the present embodiment
1200000。
Preferably, the inorganic salt copolymer superfines of vinyl methyl ether maleic acid impacts powder by high speed machine
Broken, air-flow crushing, high speed ball mill grinding obtain.
Preferably, the carrier is one of liquid paraffin, vaseline, olive oil, soybean oil or a variety of.
Embodiment 2:
A kind of firm medicament provided in this embodiment, including according to raw material made of following number proportion: vinyl methyl ether Malaysia
Inorganic 35 parts of the salt copolymer superfines of acid, 12 parts of carboxymethyl cellulose, 4 parts of microwax, 6 parts of auxiliary agent, hydroxybenzoic acid alkyl
4 parts of ester, 3 parts of tea polyphenols and carrier 18.
Preferably, the auxiliary agent includes plasticizer, colorant, preservative, aromatic, antimicrobial, bacteriostatic agent, removes
One of smelly dose or a variety of.The auxiliary agent includes aromatic, antimicrobial, bacteriostatic agent, deodorant in the present embodiment.
Preferably, the bacteriostatic agent includes Honegsukle flower P.E, propolis, Paeonol, salt.
Preferably, the aromatic is mint extract.
Preferably, preferably, the powdered molecular of the inorganic salt copolymer superfines of the vinyl methyl ether maleic acid
Amount 800000.
Preferably, the carrier is liquid paraffin, vaseline.
Embodiment 3:
A kind of firm medicament provided in this embodiment, including according to raw material made of following number proportion: vinyl methyl ether Malaysia
Inorganic 25 parts of the salt copolymer superfines of acid, 10 parts of carboxymethyl cellulose, 3 parts of microwax, 5 parts of auxiliary agent, hydroxybenzoic acid alkyl
5 parts of ester, 1 part of tea polyphenols and 15 parts of carrier.
Preferably, the auxiliary agent includes plasticizer, colorant, preservative, aromatic, antimicrobial, bacteriostatic agent, removes
One of smelly dose or a variety of.Described in the present embodiment plasticizer, colorant, preservative, aromatic, antimicrobial,
Bacteriostatic agent, deodorant.
Preferably, the powdered molecular amount 1500000 of the inorganic salt copolymer superfines of vinyl methyl ether maleic acid.
Preferably, the inorganic salt copolymer superfines of vinyl methyl ether maleic acid impacts powder by high speed machine
Broken, air-flow crushing, high speed ball mill grinding obtain.
Preferably, the carrier is one of liquid paraffin, vaseline, olive oil, soybean oil or a variety of.
Preferably, further including 1-2 parts of lysozyme.
And lysozyme 2 described in the present embodiment part.
Embodiment 4:
A kind of firm medicament provided in this embodiment, including according to raw material made of following number proportion: vinyl methyl ether Malaysia
Inorganic 45 parts of the salt copolymer superfines of acid, 15 parts of carboxymethyl cellulose, 5 parts of microwax, 8 parts of auxiliary agent, hydroxybenzoic acid alkyl
3 parts of ester, 4 parts of tea polyphenols and 20 parts of carrier.
Preferably, the auxiliary agent includes bacteriostatic agent.
Preferably, the bacteriostatic agent includes Honegsukle flower P.E, propolis, Paeonol, salt.
Preferably, the powdered molecular amount 1000000 of the inorganic salt copolymer superfines of vinyl methyl ether maleic acid.
Preferably, the inorganic salt copolymer superfines of vinyl methyl ether maleic acid impacts powder by high speed machine
Broken, air-flow crushing, high speed ball mill grinding obtain.
Preferably, the carrier is liquid paraffin, olive oil, soybean oil.
Preferably, further including 1 part of lysozyme.
Embodiment 5:
A kind of firm medicament provided in this embodiment, including according to raw material made of following number proportion: vinyl methyl ether Malaysia
Inorganic 42 parts of the salt copolymer superfines of acid, 11 parts of carboxymethyl cellulose, 3.5 parts of microwax, 6 parts of auxiliary agent, hydroxybenzoic acid alkane
4 parts of base ester, 2 parts of tea polyphenols and carrier 18 part.
Described in the present embodiment
Preferably, the auxiliary agent includes plasticizer, colorant, preservative, aromatic, antimicrobial, bacteriostatic agent.
Preferably, the bacteriostatic agent includes Honegsukle flower P.E, propolis, Paeonol, salt.
Preferably, the aromatic is mint extract.
Preferably, the powdered molecular amount 1300000 of the inorganic salt copolymer superfines of vinyl methyl ether maleic acid.
Preferably, the carrier is liquid paraffin, vaseline, olive oil, soybean oil.
When the agent for fixing component and water that the artificial tooth of the present embodiment uses contact, polymer material has water-swellable and is formed
The property of jelly, and the space between artificial tooth and gum is filled, buffer layer is formed, and improve and hold between artificial tooth and gums
Long bonding force simultaneously can be improved the safety used, at the same in inventive formulation add microwax, alkyl parabens,
The entire product that tea polyphenols and carrier refer to can remove original smell, keep certain faint scent, have the advantages that biocidal efficacies.
It is verified, the present embodiment 2 is compared with existing agent for fixing, the adhesiveness and persistence of the present embodiment 2
It is longer than existing agent for fixing, secured and heavier by using the existing agent for fixing smell of discovery, and the present invention has list
Single tea perfume, more smelling good, while also having biocidal efficacies.
The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention, for this field skill
For art personnel, it is clear that invention is not limited to the details of the above exemplary embodiments, and without departing substantially from spirit of the invention or
In the case where essential characteristic, the present invention can be realized in other specific forms.Therefore, in all respects, should all incite somebody to action
Embodiment regards exemplary as, and is non-limiting, the scope of the present invention by appended claims rather than on state
Bright restriction, it is intended that including all changes that fall within the meaning and scope of the equivalent elements of the claims in the present invention
It is interior.Although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, it is possible to understand that
A variety of change, modification, replacement and modification can be carried out to these embodiments in the case where not departing from the principle and spirit of the invention,
The scope of the present invention is defined by the appended.
Claims (10)
1. a kind of firm medicament, which is characterized in that including according to raw material made of following number proportion: vinyl methyl ether maleic acid
25-45 parts of inorganic salt copolymer superfines, 10-15 parts of carboxymethyl cellulose, 3-5 parts of microwax, 5-8 parts of auxiliary agent, hydroxy benzenes
3-5 parts of alkyl formate, 1-4 parts of tea polyphenols and 15-20 parts of carrier.
2. a kind of firm medicament according to claim 1, which is characterized in that the auxiliary agent includes plasticizer, colorant, prevents
One of rotten agent, aromatic, antimicrobial, bacteriostatic agent, deodorant are a variety of.
3. a kind of firm medicament according to claim 2, which is characterized in that the bacteriostatic agent include Honegsukle flower P.E,
Propolis, Paeonol, salt.
4. a kind of firm medicament according to claim 2, which is characterized in that the aromatic is mint extract.
5. a kind of firm medicament according to claim 1 or 2 or 3 or 4, which is characterized in that including matching according to following number
The raw material than made of: 35 parts of the inorganic salt copolymer superfines of vinyl methyl ether maleic acid, 12 parts of carboxymethyl cellulose, microwax
4 parts, 6 parts of auxiliary agent, 4 parts of alkyl parabens, 3 parts of tea polyphenols and carrier 18.
6. a kind of firm medicament according to claim 1 or 2 or 3 or 4, which is characterized in that the vinyl methyl ether Malaysia
The powdered molecular amount 800000-1500000 of the inorganic salt copolymer superfines of acid.
7. a kind of firm medicament according to claim 1 or 2 or 3 or 4, which is characterized in that the vinyl methyl ether Malaysia
The inorganic salt copolymer superfines of acid is obtained by high speed machine impact comminution, air-flow crushing, high speed ball mill grinding.
8. a kind of firm medicament according to claim 1 or 2 or 3 or 4, which is characterized in that the carrier be liquid paraffin,
One of vaseline, olive oil, soybean oil are a variety of.
9. a kind of firm medicament according to claim 1 or 2 or 3 or 4, which is characterized in that further include 1-2 parts of lysozyme.
10. a kind of firm medicament according to claim 9, which is characterized in that 2 parts of the lysozyme.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910754472.9A CN110339069A (en) | 2019-08-15 | 2019-08-15 | A kind of firm medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910754472.9A CN110339069A (en) | 2019-08-15 | 2019-08-15 | A kind of firm medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110339069A true CN110339069A (en) | 2019-10-18 |
Family
ID=68185117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910754472.9A Pending CN110339069A (en) | 2019-08-15 | 2019-08-15 | A kind of firm medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110339069A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111821498A (en) * | 2020-09-04 | 2020-10-27 | 侯常刚 | Graphene bacteriostatic, bactericidal and deodorant Chinese herbal medicine pad combined layer |
| CN112569123A (en) * | 2020-12-18 | 2021-03-30 | 安徽克菱保健科技有限公司 | Denture fixing paste with good low-temperature extrusion performance and matrix thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101663019A (en) * | 2007-05-30 | 2010-03-03 | 荷兰联合利华有限公司 | Enhanced delivery of certain fragrance components from personal care compositions |
| CN103153263A (en) * | 2010-03-10 | 2013-06-12 | 宝洁公司 | Denture adhesive compositions |
| CN105147527A (en) * | 2015-10-10 | 2015-12-16 | 博爱新开源制药股份有限公司 | Denture adhesive |
| CN108939079A (en) * | 2018-07-30 | 2018-12-07 | 郑州兰茜生物工程有限公司 | A kind of oral health agent of clearing heat and detoxicating antibacterial anti-inflammatory and preparation method thereof |
| US20190071521A1 (en) * | 2016-03-03 | 2019-03-07 | Boai Nky Medical Holdings Ltd. | Fine and Uniform Methyl Vinyl Ether-Maleic Acid Inorganic Salt Copolymers and Their Use in Oral Care and Pharmaceutical Applications |
-
2019
- 2019-08-15 CN CN201910754472.9A patent/CN110339069A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101663019A (en) * | 2007-05-30 | 2010-03-03 | 荷兰联合利华有限公司 | Enhanced delivery of certain fragrance components from personal care compositions |
| CN103153263A (en) * | 2010-03-10 | 2013-06-12 | 宝洁公司 | Denture adhesive compositions |
| CN105147527A (en) * | 2015-10-10 | 2015-12-16 | 博爱新开源制药股份有限公司 | Denture adhesive |
| US20190071521A1 (en) * | 2016-03-03 | 2019-03-07 | Boai Nky Medical Holdings Ltd. | Fine and Uniform Methyl Vinyl Ether-Maleic Acid Inorganic Salt Copolymers and Their Use in Oral Care and Pharmaceutical Applications |
| CN108939079A (en) * | 2018-07-30 | 2018-12-07 | 郑州兰茜生物工程有限公司 | A kind of oral health agent of clearing heat and detoxicating antibacterial anti-inflammatory and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 韩雅珊主编: "《抗衰老漫谈 点燃生日蛋糕上的第120根蜡烛》", 北京农业大学出版社, pages: 317 - 318 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111821498A (en) * | 2020-09-04 | 2020-10-27 | 侯常刚 | Graphene bacteriostatic, bactericidal and deodorant Chinese herbal medicine pad combined layer |
| CN112569123A (en) * | 2020-12-18 | 2021-03-30 | 安徽克菱保健科技有限公司 | Denture fixing paste with good low-temperature extrusion performance and matrix thereof |
| CN112569123B (en) * | 2020-12-18 | 2023-04-11 | 安徽克菱保健科技有限公司 | Denture fixing paste with good low-temperature extrusion performance and matrix thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Melo et al. | Novel dental adhesive containing antibacterial agents and calcium phosphate nanoparticles | |
| Liang et al. | Dentin remineralization in acid challenge environment via PAMAM and calcium phosphate composite | |
| Ray Jr et al. | Long‐term follow up of revascularization using platelet‐rich fibrin | |
| US8889196B2 (en) | Dental composites comprising nanoparticles of amorphous calcium phosphate | |
| EP1566160B1 (en) | Antimicrobial dental composition | |
| NZ601200A (en) | Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) | |
| WO2008140936A3 (en) | Oral care composition to reduce or eliminate dental sensitivity | |
| He et al. | A suitable base material for composite resin restorations: zinc oxide eugenol | |
| EP3492069A3 (en) | Pharmaceutical compositions | |
| TW201119682A (en) | Composition for oral cavity | |
| CN110339069A (en) | A kind of firm medicament | |
| CN113795236B (en) | Root canal filling material composition | |
| JP2018016635A (en) | Oral composition | |
| CN105147527B (en) | A kind of the study of denture adhesive | |
| Ülker et al. | Cytotoxicity testing of temporary luting cements with two‐and three‐dimensional cultures of bovine dental pulp‐derived cells | |
| US20180344579A1 (en) | Dental composition containing ion sustained-release glass | |
| Zavattini et al. | Bonding ability of experimental resin-based materials containing (ion-releasing)-microfillers applied on water-wet or ethanol-wet root canal dentine | |
| Jose’de Souza Filho et al. | Innovations in endodontic filling materials: guttapercha vs Resilon | |
| Yang et al. | Nanotechnology in dental therapy and oral tissue regeneration | |
| CN101304723B (en) | Denture adhesive compositions | |
| WO2015046491A1 (en) | One-component-type dentinal tubule sealant | |
| JP6613878B2 (en) | Oral polymer gel formulation | |
| JP2020083831A (en) | Dentifrice composition | |
| JP4979971B2 (en) | Dental treatment solvent | |
| Al-Azzawi | The effect of waterlase laser and herbal alternative, green tea and Salvadora Persica (Siwak) extract on push-out bond strength |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191018 |
|
| RJ01 | Rejection of invention patent application after publication |